High-throughput RNAi screen for essential genes and drug synergistic combinations in colorectal cancer (vol 4, 170139, 2017)

被引：0

作者：

Williams, Steven P.

Barthorpe, Andrew S.

Lightfoot, Howard

Garnett, Mathew J.

McDermott, Ultan

机构：

[1] (email:,

来源：

SCIENTIFIC DATA | 2018年 / 5卷

关键词：

D O I：

10.1038/sdata.2018.215

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Correction to: Scientific Data https://doi.org/10.1038/sdata.2017.139, published online 03 October 2017. The Data Descriptor incorrectly states the formula used to calculate the Bliss additivity score in the Data analysis subsection of the Methods. The correct equation is listed below: Blissadditivity=1–(1–VsiRNA)–(1–Vanchor)+((1–VsiRNA)×(1–Vanchor))

引用

页数：1

共 50 条

[41] High-throughput sequencing reveals crebanine inhibits colorectal cancer by modulating Tregs immune prognostic target genes
Xu, Jiajun
Huang, Lingyu
Sha, Yu
Mo, Chune
Gong, Weiwei
Tian, Xiayu
Hou, Xianliang
Chen, Wei
Ou, Minglin
ONCOLOGIE, 2024, 26 (04) : 643 - 656
[42] Clonal Expansion Analysis of Transposon Insertions by High-Throughput Sequencing Identifies Candidate Cancer Genes in a PiggyBac Mutagenesis Screen
Friedel, Roland H.
Friedel, Caroline C.
Bonfert, Thomas
Shi, Ruijin
Rad, Roland
Soriano, Philippe
PLOS ONE, 2013, 8 (08):
[43] A CLIA-CERTIFIED HIGH-THROUGHPUT DRUG SCREENING PLATFORM FOR OVARIAN CANCER TO INFORM PERSONALIZED CANCER CARE AND DISCOVER NOVEL COMBINATIONS
Schaub, Franz X.
Maisel, Sabrina
Shaw, Reid
Rosati, Rachele
Bridgwater, Caroline
Churchill, Michael
Diaz, Robert
Murphy, Stephanie Tatem
Pereira, Shalini
Kemp, Christopher
Gadi, V. K.
Grandori, Carla
CLINICAL CANCER RESEARCH, 2019, 25 (22) : 114 - 114
[44] Unbiased High-Throughput Drug Combination Pilot Screening Identifies Synergistic Drug Combinations Effective against Patient-Derived and Drug-Resistant Melanoma Cell Lines
Close, David A.
Kirkwood, John M.
Fecek, Ronald J.
Storkus, Walter J.
Johnston, Paul A.
SLAS DISCOVERY, 2021, 26 (05) : 712 - 729
[45] An unbiased high-throughput drug screen reveals a potential therapeutic vulnerability in the most lethal molecular subtype of pancreatic cancer
Pan, Chun-Hao
Otsuka, Yuka
Sridharan, BanuPriya
Woo, Melissa
Leiton, Cindy V.
Babu, Sruthi
Torrente Goncalves, Mariana
Kawalerski, Ryan R.
K. Bai, Ji Dong
Chang, David K.
Biankin, Andrew V.
Scampavia, Louis
Spicer, Timothy
Escobar-Hoyos, Luisa F.
Shroyer, Kenneth R.
MOLECULAR ONCOLOGY, 2020, 14 (08) : 1800 - 1816
[46] Murine-derived colorectal cancer organoid culture high-throughput drug screening to identify novel combinations targeting PIK3CA mutant cancers
DeZeeuw, Alyssa K.
DeStefanis, Rebecca A.
Sha, Gioia
Pasch, Cheri A.
Clipson, Linda
Deming, Dustin A.
CANCER RESEARCH, 2020, 80 (16)
[47] High-throughput sequencing reveals twelve cell death pattern prognostic target genes as potential drug-response-associated genes in the treatment of colorectal cancer cells with palmatine hydrochloride
Luo, Sha
Xu, Jiajun
Mo, Chune
Gong, Weiwei
Li, Chunhong
Hou, Xianliang
Ou, Minglin
ONCOLOGIE, 2025, 27 (01) : 167 - 184
[48] A High-Throughput Drug Screen Reveals a Novel Compound Class That Significantly Depletes IRF4 Expression in Multiple Myeloma
Lightbody, Elizabeth D.
Reidy, Mairead
Agius, Michael P.
El-Behaedi, Salma
Sklavenitis-Pistofidis, Romanos
Manier, Salomon
Ghobrial, Irene M.
BLOOD, 2019, 134
[49] High-throughput matrix screening in ovarian cancer cells identifies synergistic drug combinations with the second mitochondrial-derived activator of caspases (SMAC) mimetic birinapant (TL32711)
Bunch, K. P.
Goldlust, I. S.
Thomas, C. J.
Annunziata, C. M.
GYNECOLOGIC ONCOLOGY, 2015, 137 : 207 - 208
[50] Lung cancer stem cell targets sensitizing tumor cells to chemo therapy and radiation therapy by exploiting synthetic lethal relationships in an RNAi high-throughput screen
Chaudhary, Kunal R.
Cheng, Haiying
Halmos, Balaz
Silva, Jose M.
Chao, K. S. Clifford
Hei, Tom K.
Cheng, Simon
CANCER RESEARCH, 2015, 75

← 1 2 3 4 5 →